NCT05756595View on ClinicalTrials.gov

A Clinical Study of Freshly Manufactured 35kDa Hyaluronan Fragment in the Treatment of Pain

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 6, 2020

Primary Completion Date

December 29, 2022

Study Completion Date

February 8, 2023

Conditions
Shoulder PainNeck PainBack PainTemporal PainHerpes Zoster Pain
Interventions
DRUG

HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)

This group will inject once a week. Evaluation of pain score after 30 seconds and 3 hours.

Trial Locations (1)

266000

Qingdao University Affiliated Hospital, Qingdao

All Listed Sponsors
collaborator

The Affiliated Hospital of Qingdao University

OTHER

collaborator

Nakhia Impex LLC

INDUSTRY

lead

Dove Medical Press Ltd

NETWORK

NCT05756595 - A Clinical Study of Freshly Manufactured 35kDa Hyaluronan Fragment in the Treatment of Pain | Biotech Hunter | Biotech Hunter